Lippman commented, "We are grateful to each of the 387 Houston-area men who committed to participating in this study through M. D. Anderson. Prevention trials are an important direction for the future of cancer research. SELECT played an important role in the study of the prevention of prostate cancer and we hope to learn more about why these supplements didn't do more to prevent prostate cancer as the study continues."
'/>"/>
| Contact: Robin Davidson rdavidson@mdanderson.org 713-794-1731 University of Texas M. D. Anderson Cancer Center Source:Eurekalert |